Literature DB >> 18793114

Circulating endothelial progenitor cells in cardiovascular disorders.

Dael Geft1, Shmuel Schwartzenberg, Jacob George.   

Abstract

The role of vascular endothelium in cardiovascular disorders is well recognized. Mature endothelial cells contribute to the repair of endothelial injury, but only with a limited capacity. This has led to growing interest and further investigation into circulating endothelial progenitor cells (EPCs) and their role in vascular healing, repair and postnatal neovascularization. Recent studies have shown that EPCs are affected both in number and function by several cardiovascular risk factors as well as various cardiovascular disease states. Here, we aim to provide an overview of EPCs in humans, from methods of assessment to quantification and functional properties in numerous cardiovascular conditions. In addition, we hope to offer some perspective on the potential diagnostic and therapeutic aspects of EPCs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18793114     DOI: 10.1586/14779072.6.8.1115

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  3 in total

1.  Aneurysm Development in Patients With Bicuspid Aortic Valve (BAV): Possible Connection to Repair Deficiency?

Authors:  Shohreh Maleki; Hanna M Björck; Valentina Paloschi; Sanela Kjellqvist; Lasse Folkersen; Veronica Jackson; Anders Franco-Cereceda; Per Eriksson
Journal:  Aorta (Stamford)       Date:  2013-06-01

Review 2.  Stimulation of endothelial progenitor cells: a new putative effect of several cardiovascular drugs.

Authors:  Natália António; Rosa Fernandes; Noela Rodriguez-Losada; Manuel F Jiménez-Navarro; Artur Paiva; Eduardo de Teresa Galván; Lino Gonçalves; Carlos Fontes Ribeiro; Luís A Providência
Journal:  Eur J Clin Pharmacol       Date:  2009-12-10       Impact factor: 2.953

3.  An affordable method to obtain cultured endothelial cells from peripheral blood.

Authors:  Carlos Bueno-Betí; Susana Novella; Macarena Lázaro-Franco; Daniel Pérez-Cremades; Magda Heras; Juan Sanchís; Carlos Hermenegildo
Journal:  J Cell Mol Med       Date:  2013-10-01       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.